The authors found that women with overweight/obesity had an increased invasive BC risk compared with women with normal weight, and elevated BMI (≥ 35) resulted associated with risk for estrogen/progesterone receptor‐positive (ER+/PR+) BCs. Here, PGR is linked to obesity due to melanocortin 4 receptor deficiency.